sPIF

Christopher O'Brien, MD · Phase 1 active Small molecule

At a glance

Generic name	sPIF
Also known as	synthetic PreImplantation Factor
Sponsor	Christopher O'Brien, MD
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS (PHASE1)
Phase II AutoImmune Hepatitis (PHASE2)
Phase 2 Dose Finding sPIF in Patients With High Panel Reactive Antibodies (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

sPIF CI brief — competitive landscape report
sPIF updates RSS · CI watch RSS
Christopher O'Brien, MD portfolio CI